— Know what they know.
Not Investment Advice

CNTMF OTC

Fluent Corp.
1W: +0.1% 1M: +0.9% 3M: +2.2% YTD: -56.8% 1Y: -57.4% 3Y: -74.4% 5Y: -96.6%
$0.02
+0.00 (+0.00%)
 
Weekly Expected Move ±13.3%
$0 $0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 50 · $10.8M mcap · 146M float · 0.230% daily turnover · Short 50% of daily vol

Income Trends

Revenue
$104M +6.4% ▲
5Y CAGR: +29.4%
Gross Profit
$55M +14.8% ▲
5Y CAGR: +24.8%
Operating Income
$7M -29.5% ▼
Net Income
-$40M -77.5% ▼
EPS (Diluted)
$-0.13 -67.3% ▼
EBITDA
$1M -94.5% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$52M$65M$88M$97M$104M
YoY Growth+83.7%+24.9%+34.0%+10.9%+6.4%
Cost of Revenue$23M$30M$51M$50M$49M
Gross Profit$30M$36M$37M$48M$55M
Gross Margin57.0%54.7%42.2%48.9%52.7%
R&D Expenses$0$0$0$0$0
SG&A Expenses$32M$30M$27M$31M$37M
Operating Expenses$38M$36M$34M$38M$48M
Operating Income-$8M-$3M$3M$9M$7M
Operating Margin-16.1%-4.7%3.4%9.5%6.3%
Interest Expense$14M$16M$16M$18M$20M
Income Before Tax-$30M-$11M-$27M-$9M-$34M
Tax Expense$6M$8M$10M$14M$7M
Net Income-$37M-$19M-$37M-$23M-$40M
Net Margin-70.1%-29.0%-42.4%-23.4%-39.0%
EPS (Diluted)$-0.18$-0.08$-0.15$-0.08$-0.13
EBITDA-$8M$7M$3M$24M$1M
Shares Outstanding199M229M253M293M356M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms